Posted in | News

SunPower to Construct Three Solar Plants in Italy

SunPower Corp. (Nasdaq: SPWRA, SPWRB) and Solar Ventures S.r.l., a developer of solar parks in Italy, France and the Mediterranean area, today announced that they have signed a contract to design and build three solar power plants in the Piedmont region of Italy.

Totaling 11.1 megawatts over 30 hectares, the development represents one of the largest solar power developments in the region. Construction on the plants will start this month and is expected to be completed by the end of the year.

"We are delighted to partner with Solar Ventures to deliver reliable, emission-free solar power to the community and continue the rapid expansion of the Italian solar market," said Mario Riello, EMEA Sales Director for SunPower Utility and Power Plants division. "This project reinforces SunPower's impressive track record in Italy where both development partners and financing institutions praise our bankability, high performance technology, and project execution."

On fixed-tilt, ground-mounted systems, SunPower will mount standard-efficiency solar panels, including SunPower Serengeti panels, which offer the same high quality, reliable energy delivery and 25-year warranty as SunPower's high-efficiency panel offerings.

"Solar Ventures built its first photovoltaic plant in Piedmont in 2007, where we have experienced excellent community and administration support for solar park development, as well as good irradiance levels," said Michele Appendino, CEO and chairman of Solar Ventures. "We have therefore decided to focus our development efforts in this region, where we have other similar clusters of plants under construction this year. We are happy to work with SunPower, whose technology will deliver clean and renewable solar power for many years to come."

Source: http://www.sunpowercorp.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.